ストックスクリーナーアプリを入手
0.4534
6.98%
0.0296
アフターアワーズ：
.44
-0.0134
-2.96%
前日終値:
$0.4238
開ける：
$0.4238
24時間の取引高:
1.87M
Relative Volume:
0.24
時価総額：
$66.48M
収益：
$49.09M
当期純損益:
$-52.15M
株価収益率:
-0.6975
EPS:
-0.65
ネットキャッシュフロー:
$-45.93M
1週間 パフォーマンス:
+14.41%
1か月 パフォーマンス:
+25.94%
6か月 パフォーマンス:
-48.59%
1年 パフォーマンス:
-74.24%
1日の値動き範囲:
$0.41
$0.4599
1週間の範囲:
$0.3844
$0.4599
52週間の値動き範囲:
$0.1718
$2.04
Biodesix Inc Stock (BDSX) Company Profile
BDSX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.4534 | 62.32M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-07-26 | 開始されました | Craig Hallum | Buy |
| 2024-05-13 | 開始されました | TD Cowen | Buy |
| 2024-05-03 | 開始されました | Lake Street | Buy |
| 2021-11-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 開始されました | BTIG Research | Buy |
| 2020-11-23 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-23 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-23 | 開始されました | William Blair | Outperform |
すべてを表示
Biodesix Inc (BDSX) 最新ニュース
Fibonacci Support Holding Strong in Biodesix Inc.July 2025 Institutional & Weekly Sector Rotation Insights - classian.co.kr
Will Biodesix Inc. Reverse From Oversold ConditionsQuarterly Performance Summary & AI Based Buy and Sell Signals - beatles.ru
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewswire
Biodesix Designated Thermo Fisher Center of Excellence for NGS-Based Diagnostics. - AInvest
Biodesix Validates Thermo Fisher's Oncomine Dx Express Test for Solid Tumors on Genexus Dx Integrated Sequencer. - AInvest
Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing - Stock Titan
Wyckoff Accumulation Phase Possible in Biodesix Inc.July 2025 Review & Long-Term Growth Stock Strategies - newsimpact.co.kr
Options Data Show Bullish Bias in Biodesix Inc.July 2025 Breakouts & AI Enhanced Market Trend Forecasts - newsyoung.net
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
What makes Biodesix Inc. stock price move sharplyBond Market & Short-Term Trading Alerts - thegnnews.com
Biodesix Inc. Stocks Attracting Dip BuyersJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - newsyoung.net
Is This the Dip to Buy in Biodesix Inc.Wall Street Watch & AI Driven Price Predictions - newsimpact.co.kr
What MACD and RSI say about Biodesix Inc.Portfolio Risk Summary & Weekly Breakout Watchlists - Newser
Biodesix (NASDAQ:BDSX) Releases Earnings Results - MarketBeat
Combining machine learning predictions for Biodesix Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Price momentum metrics for Biodesix Inc. explainedJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Combining price and volume data for Biodesix Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - Newser
AI Indicators Detect Buy Opportunity in Biodesix Inc.CEO Change & Fast Entry and Exit Trade Plans - kangso.co.kr
Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com
Will Biodesix Inc. Benefit From Sector TailwindsTrade Performance Summary & Low Volatility Stock Recommendations - newsimpact.co.kr
Blair William & Co. IL Has $78,000 Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Is a relief rally coming for Biodesix Inc. holders2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Will Biodesix Inc. bounce back from current supportFed Meeting & Risk Managed Investment Strategies - Newser
Earnings visualization tools for Biodesix Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Is Biodesix Inc. a strong growth stockUndervalued High Return Candidates - kangso.co.kr
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Should I add Biodesix Inc. stock to my portfolioMulti-Year Breakout Candidates - thegnnews.com
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - The Manila Times
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix Inc (BDSX) 財務データ
収益
当期純利益
現金流量
EPS
Biodesix Inc (BDSX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
| Vazquez Chris | Chief Accounting Officer |
May 12 '25 |
Sale |
0.36 |
112 |
40 |
18,113 |
| Vazquez Chris | Chief Accounting Officer |
May 13 '25 |
Sale |
0.35 |
112 |
40 |
18,001 |
| Pestano Gary Anthony | Chief Development Officer |
May 12 '25 |
Sale |
0.36 |
223 |
80 |
157,163 |
| Pestano Gary Anthony | Chief Development Officer |
May 13 '25 |
Sale |
0.35 |
222 |
78 |
156,941 |
4.05%
1.90%
大文字化:
|
ボリューム (24 時間):